Article

One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent

Nabijon YuldashevRepublican Specialized Center of Cardiology, Tashkent, UzbekistanRobert GilCentral Clinical Hospital of the Internal Affairs and Administration Ministry, Warsaw, PolandR. D. KurbanovRepublican Specialized Center of Cardiology, Tashkent, Uzbekistan

International Journal of Biomedicinejournal2018en

ABI

Abstract

The aim of this study was to evaluate the immediate and long-term (12 months) clinical and angiographic efficacy of myocardial revascularization using Absorb GT1 Bioresorbable Vascular Scaffold (BVS) in comparison to second-generation drugeluting stent (DES) in patients with various forms of coronary artery disease (CAD).

Topics

Coronary Interventions and Diagnostics Cardiac and Coronary Surgery Techniques Antiplatelet Therapy and Cardiovascular Diseases

Identifiers

DOI: 10.21103/article8(1)_oa2

Citations and references

Cited by 010 references

Metrics — AkademScholar